July 2023 Newsletter

Welcome to the July Cresset Newsletter

Win the race to scientific success with this month's collection of CADD software applications, expert scientific opinion and first class drug discovery research resources.

You can subscribe to our monthly newsletter list if you'd like to receive these monthly updates via email.

Flare Ensemble Covalent Docking Newsletter Image

Covalent Docking in Flare™: Ensemble Covalent Docking

The recently added 'Ensemble Covalent' docking experiment in Flare enables users to consider protein active site flexibility in their docking experiments for covalently bound inhibitors. To illustrate the new feature, in her recent article, our Application Scientist, Jessica Plescia used the example compound KYP-2047, a prolyl oligopeptidase (POP) inhibitor.

Customized force field parameters using DFT//GFN2-xTBCustomized force field parameters using a hybrid DFT//GFN2-xTB approach

The new hybrid DFT//GFN2-xTB workflow in Flare can generate accurate torsional energy profiles for custom force field parameterization of novel molecules. This helps users to obtain accurate and reliable thermodynamic properties for Molecular Dynamics (MD) and Free Energy Perturbation (FEP) calculations.

Dr Rob ScoffinNavigating unprecedented changes in the biotechnology and biochemistry sectors

Rob Scoffin, Cresset CEO, spoke to the Life Sciences Knowledge Hub about the rising trends in the need for CADD software and contract research and driving innovation through collaborative drug discovery.

Drug repurposing for ovarian cancer newsletter imageFast-tracking drug repurposing research

The Australian Program for Drug Repurposing for Treatment-Resistant Ovarian Cancer is working with Cresset Discovery, as part of a world-first drug repurposing program for ovarian cancer. Our recent case study summarizes the project.

Caspase-3 protein in molecular modelling platform, FlareFlare V7: what’s new for ligand-based and structure-based drug designers?

Last month, our Principal Application Scientists, Stuart Firth-Clark and Nathan Kidley led an exclusive online webinar, guiding attendees through the new Flare V7 features, using a worked example of the Caspase-3 protein, a target for inflammation and cancer drug discovery.

Boston Area Group for Informatics and Modelling (BAGIM)The Open Force Field Initiative: An update on its progress and plans

Since 2020, we’ve been working in collaboration with Open Force Field, providing Flare users with access to their force fields in MD and FEP calculations. Last month we were proud to work together through a virtual event, hosted by the Boston Area Group for Informatics and Modeling.

Nick Foster, Vice President of Cresset Discovery CROCresset Creates New Vice President Role to Lead their Discovery CRO Business

We’ve created a new Vice President role to lead our Discovery CRO business. Nick Foster will be responsible for driving the strategic direction of Cresset’s Discovery CRO business, ensuring organizations have access to the deepest molecular modeling expertise in the industry.

Using Hit Expander and QSAR to Design and Score New Ligands In Silico

1055x250_Hit Expander + QSAR

In our next webinar, scheduled for Thursday 17th August, we will be presenting a case study that uses the new Hit Expander component of Flare to design a new library of analogues, and subsequently predict the relative binding affinity of each analogue against our target protein. If you haven't already, register here to join the webinar.

External Conferences, Exhibitions & Events

Cresset are due to be attending, exhibiting, and/or presenting at the following events. Further details can be found via our upcoming events schedule.

Gordon Research Conference: Data Analytics and Computational Modeling for Next Generation Molecular Design
16 - 21 JULY, 2023 | VERMONT, USA

CBI Seminar Japan

ACS Fall 2023 Harnessing the Power of Data


Request a software evaluation, Torx® demo or Discovery CRO discussion

Contact us today